Hemangioma, Cavernous: Clinical Trials

5 trials for Hemangioma, Cavernous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Terminated 1
Phase 11Completed 1

Follow Hemangioma, Cavernous: new trials by email Literature Review of Hemangioma, Cavernous trials Research Report on Hemangioma, Cavernous

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
REC-994, Placebo - Cerebral Cavernous Malformation
Phase 2CompletedRecursion Pharmaceuticals Inc.622022-03-172026-10-22
Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
Atorvastatin, Placebo - Cerebral Cavernous Malformation
Phase 1 / Phase 2CompletedUniversity of Chicago802018-07-172025-08-22
Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation
Propranolol - Cerebral Cavernous Malformation
Phase 2CompletedMario Negri Institute for Pharmacological Research712018-04-112022-02-25
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
Propranolol, DNA and RNA Analysis - Cerebral Cavernous Malformations
Phase 2TerminatedSt. Joseph's Hospital and Medical Center, Phoenix42018-01-242024-04-19
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
timolol maleate 0.5% gel - Hemangioma
Phase 2CompletedRady Children's Hospital, San Diego262014-05-012017-02-13

Narrower conditions

Hemangioma, Cavernous, Central Nervous System (4)  ·  Hemangioma (1)

Broader conditions

Brain Diseases (5)  ·  Cardiovascular Diseases (5)  ·  Cavernous Sinus Syndromes (5)  ·  Central Nervous System Diseases (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Hemorrhagic Disorders (5)  ·  Hemostatic Disorders (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Vascular Tissue (5)  ·  Nervous System Diseases (5)  ·  Vascular Diseases (5)  ·  Cardiovascular Abnormalities (4)  ·  Central Nervous System Vascular Malformations (4)

Interventions

Propranolol (2)  ·  Atorvastatin (1)  ·  DNA (1)  ·  Gels (1)  ·  Timolol (1)

Sponsors

Mario Negri Institute for Pharmacological Research (1)  ·  Rady Children's Hospital, San Diego (1)  ·  Recursion Pharmaceuticals Inc. (1)  ·  St. Joseph's Hospital and Medical Center, Phoenix (1)  ·  University of Chicago (1)

Countries

United States (4)  ·  Italy (1)

Top investigators

Daniel F Hanley, MD (1)  ·  Elisabetta Dejana, Professor (1)  ·  Issam A Awad, MD (1)  ·  Joseph Zabramski, MD (1)  ·  Roberto Latini (1)  ·  Sheila F Friedlander, MD (1)

Results publications

PMID 32398113, PMID 36403580, PMID 38419711, PMID 40120614, PMID 40570636, PMID 41117517, PMID 41608890

NIH funding

2017 (1)